Tổng Quan
- Danh pháp khoa học
- Artemisia herba-alba
- Họ thực vật
- Asteraceae (Compositae)
- Bộ phận dùng
- Leaves and flowering tops
- Phương pháp chiết xuất
- Steam distillation (essential oil); Solvent extraction (absolute from concrete) — B216 EXPLICIT 2...
- Màu sắc
- Pale yellow to golden-amber clear-mobile-liquid
- Phân loại nốt hương
- Nốt Top/Middle
- Hương thơm
- —
- Chemotype / Cultivar
- alpha-thujone-camphor
Tình trạng tại Việt Nam
Xem chi tiết
strongly-camphoraceous bitter herbaceous slightly-eucalyptus-medicinal dry-desert-arid slightly-floral-sage-undertones distinctive-Maghreb-aromatic
mạnh long-não, đắng sắc, thảo mộc, hơi-bạch-đàn-y-tế, khô sa-mạc, hơi-hoa-xô-thơm-nền, KHÔNG ngọt như thanh-hao-hoa-vàng, KHÔNG biển như ngải-biển, đặc-trưng-Maghreb-truyền-thống
2–4 giờ
Tên gọi tại Việt Nam
Pha Chế & Hòa Hợp
Artemisia herba-alba EO demonstrated antigenotoxic activity in diploid yeast against UVC radiation, 8-MOP+UVA, and methyl methanesulfonate (MMS) DNA-damaging agents; constituent basis uncertain but likely includes terpenoid antioxidant pool across the camphor/thujone/chrysanthenyl-acetate matrix.
Ref: Bakkali F et al. (2006). Mutation Research 606(1-2):27–38.
Camphor 34–55% (CT VI primary commercial constituent) stimulates TRPV1/TRPM8 thermoreceptors at trace concentrations, producing mild warming sensation and localised circulation increase when applied within the 0.25% hard cap; therapeutic magnitude is modest at this extreme dilution.
Ref: Tisserand & Young 2014, Ch.13–14 (camphor constituent profile, TRPV1 mechanism); class-extrapolation from camphor EO
Dry-herbaceous, smoky-camphoraceous odour profile from camphor, α/β-thujone, davanone, and chrysanthenyl acetate provides fixative depth and vintage-leather-tobacco facets at trace 0.05–0.25% concentrations in classical French perfumery structures.
Ref: Arctander S. (1960). Perfume and Flavor Materials of Natural Origin. Elizabeth NJ: Author.
Camphor (34–55%) and α/β-thujone (up to 46% combined, CT VI) disrupt microbial membrane integrity and enzyme function; effect at the 0.25% dermal cap is below concentrations tested in vitro — rating reflects constituent-class activity, not aromatherapy-dose therapeutic outcome.
Ref: class-extrapolation from Artemisia absinthium (wormwood EO825); Tisserand & Young 2014, Ch.13–14
Thujone isomers and camphor show documented antifungal membrane-disruption activity against Candida and dermatophyte species in vitro; clinical antifungal effect at the 0.25% dermal cap is not established — rating reflects in vitro constituent-class activity only.
Ref: class-extrapolation from Artemisia absinthium (wormwood EO825); Tisserand & Young 2014, Ch.13
Traditional Bedouin/Maghreb aqueous decoctions used for digestive, anthelmintic, and antidiabetic purposes (Al-Khalil 1995; Gabay 2007); responsible actives are non-volatile sesquiterpene-lactones absent from the steam-distilled EO — oral EO is contraindicated per B216 EXPLICIT.
Ref: Al-Khalil S. (1995). Int J Pharmacognosy 33(4):317–323; Gabay R. (2007). Israel J Plant Sciences 55:153–158
AI-summary
No RCT-grade clinical aromatherapy evidence located. Opdyke (1975) found Moroccan wormwood oil neither irritating nor sensitising at 12% in 25 volunteers (non-phototoxic) — a safety baseline well above the 0.25% cap, no therapeutic outcomes measured. Bakkali et al. (2006) demonstrated antigenotoxic activity in Saccharomyces cerevisiae in vitro against UVC, 8-MOP+UVA, and MMS — mechanistically noteworthy but not a clinical aromatherapy trial. Höld et al. (2000) characterised α-thujone as a GABA-A receptor modulator, establishing the neurotoxicity mechanism — a hazard finding, not a therapeutic benefit. Ethnopharmacological records (Al-Khalil 1995; Gabay 2007) document aqueous PLANT decoctions (digestive, antidiabetic) in Bedouin and Maghreb tradition; non-volatile actives are absent from the steam-distilled EO, and oral EO use is contraindicated per B216 EXPLICIT.
NarrativeTâm trạng: Stimulating, Grounding
Chakra
third-eye
Ngũ hành
kim
| Phương pháp | Liều lượng | Ghi chú |
|---|---|---|
| Diffusion (ultrasonic / nebuliser) | 1–2 drops per 200 mL water; max 10–15 min per session | Specialist use only; thujone+camphor inhalation risk. Well-ventilated room only. Contraindicated: pregnancy, breastfeeding, children, epilepsy, anticonvulsant/benzodiazepine medication. |
| Topical massage blend | Max 0.25% in carrier oil (= 1 drop per 20 mL carrier) | HARD CAP 0.25% adult maximum. Contraindicated: pregnancy, breastfeeding, children. Avoid mucous membranes and face. Adults only. Patch-test before extended use. |
| Perfumery / cosmetic formulation (trace fixative) | 0.05–0.25% in finished formulation | Primary legitimate commercial application. Trace fixative for chypre/leather/tobacco accords. Absolute form preferred. Label camphor content per applicable cosmetic regulations. |
| Aromatic compress | 1–2 drops dispersed in 1 L warm water with emulsifier; apply via cloth | Adults only, ≤10 min exposure. Not near face or chest. Effective at <0.1%. Contraindicated: pregnancy, breastfeeding, children. Modest counter-irritant effect only. |
Dầu nền phù hợp
Kết hợp tốt với
Blend kinh điển
Chưa có dữ liệu tham khảo.
An Toàn
Giới hạn da tối đa
Xem chi tiết
Giới hạn IFRA
Xem chi tiết
Thai kỳ & Cho con bú
Giới hạn độ tuổi
Xem chi tiết
Bảo quản
Bảo quản nơi tối, mát